RxDoctor Payments Data

Allison Goddard

Dermatology · Falmouth, MENPI 1043447915

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $8,245 of the $10,947 with a category attached, or 75.3%. Helsinn Therapeutics (U.S.), Inc. accounts for 80.6% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $9,246 and has fallen 96.8% since, to $292 in 2025. Among dermatology clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,947in general payments, 2019–2025

Across 92 payments — averaging $118.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Helsinn Therapeutics (U.S.), Inc.$9K
  • Johnson & Johnson$287
  • Arcutis Biotherapeutics, Inc.$196
  • E.r. Squibb & Sons, L.L.C.$191
  • Dermavant Sciences, Inc.$182
  • Regeneron Healthcare Solutions, Inc.$158
  • plus $1K from 19 others

What the payments were for

  • Speaking & faculty fees$8,24575%
  • Travel & lodging$4614%
  • Food & beverage$2,24120%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,947 in reported general payments places this provider in the 95th percentile of 46 dermatology providers in Maine.

See all dermatology providers in Maine

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast16$71,657
Clobetasol Propionate44$1,954
Doxycycline Monohydrate16$649
Metronidazole12$641
Triamcinolone Acetonide12$155

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$118$71,65716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 46 dermatology providers in Maine.

Other dermatology in Falmouth

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →